Democratic People's Republic of Korea national influenza programme: influenza factsheet 2020

Democratic People’s Republic of Korea Influenza Surveillance – Landscape Analysis 2020 INFLUENZA FACTSHEET 2020 DEMOCRATIC PEOPLE’S REPUBLIC OF KOREA National Influenza Programme Basic information (2020) Total population 25 448 350 (CBS) Children <5 years 1 634 797 (CBS) Under-5 mortality rate (per 1000 live births) 16.5 (CBS) Life expectancy at birth (years) 74.1 (CBS) Provinces/divisions/regions/zones 13 (9 provinces, 4 cities) Districts 209 Total health expenditure (% of GDP) 7.01 Income level (World Bank) Low3 1https://www.who.int/southeastasia/health-topics/immunization 2https://www.who.int/gho/publications/world_health_statistics/2020/en/ 3https://data.worldbank.org/ Influenza Like Illness (ILI) Surveillance Type of ILI surveillance Sentinel Sentinel sites involved in ILI surveillance Primary health centres Surveillance case definition used for ILI case ascertainment WHO 2014 Is laboratory confirmation sought in ILI cases? Yes, 10% of enrolled ILI cases are tested Number of ILI sentinel surveillance sites 48 Number of states/districts covered by the ILI surveillance system 9 provinces & 4 municipalities % of the population covered by the ILI surveillance system 100% Denominator used for ILI surveillance Number of outpatient visits Reporting frequency to the national level Weekly Type of data reported Aggregated Form of the data reporting tool Electronic Severe Acute Respiratory Infection (SARI) Surveillance Type of SARI surveillance Sentinel Sentinel sites involved in SARI surveillance Hospitals (inpatients) Surveillance case definition used for SARI case ascertainment WHO 2014 Is laboratory confirmation sought in SARI cases? Yes, all enrolled cases are tested Number of SARI sentinel surveillance sites 68 Number of states/districts covered by the SARI sentinel surveillance system 9 provinces & 4 municipalities % of the population covered by the surveillance system 100% Denominator used for SARI surveillance Number of inpatient visits Reporting frequency to the national level Weekly Type of data reported Aggregated Form of the data reporting Electronic Influenza Surveillance – Landscape Analysis 2020 Democratic People’s Republic of Korea Intensive Care Unit (ICU) surveillance Does the country have surveillance for influenza in the ICU? Yes Is laboratory confirmation sought in ICU cases? Yes, for all ICU cases Is case-based information collected? Yes Mortality surveillance Is timely all-cause mortality data (i.e. within one month) available in the country? Yes Virological surveillance system Does the country have virological surveillance? Yes Type of virological surveillance Sentinel – If sentinel, the number of sites involved 116 Is epidemiological case information collected? Yes – If yes, are the laboratory results linked to epidemiological data? Yes The average number of virological samples processed per week 30 Are samples processed from ILI or SARI surveillance systems? Yes, from both systems Does the country have virus isolation capacity? Yes Does the country have RT-PCR capacity? Yes – % labs that perform RT-PCR – – % RT-PCR labs that report to NIC – Does the country use rapid diagnostic testing for influenza surveillance? Yes – immunochromatography Does the country have sequencing capacity? No Does the country test for other respiratory viruses? Yes Influenza Like Illness (ILI ) Surveillance: the number and the proportion of ILI cases per 1000 outpatients, 2019–2020 Democratic People’s Republic of Korea Influenza Surveillance – Landscape Analysis 2020 Severe Acute Respiratory infections (SARI) Surveillance: The number of severe acute respiratory infection (SARI) cases, 2018–2020 Source: GISRS/ FLUMART (http://apps.who.int/flumart/) National Influenza Centre Does the country have a National Influenza Centre (NIC) or national laboratory? Yes, NIC (established in 2009) Assays routinely performed at the NIC or national laboratory PCR Does the NIC have – Virus isolation capability – Antigenic characterisation capability – Antiviral susceptibility testing capability – Sequencing capability Yes Yes Yes No Does the NIC test for other respiratory viruses? Yes – Respiratory Syncytial Virus, Coronaviruses Does the country have a quality control plan? Yes Does the country follow national biosafety and biosecurity policy guidelines? Yes Does the country forward samples to a WHO CC? No – How often? Not applicable Virological surveillance: The number and percentage of specimens positive for influenza and subtypes, 2018–2020 Influenza Surveillance – Landscape Analysis 2020 Democratic People’s Republic of Korea For technical information, please contact: Dr Pushpa Ranjan Wijesinghe, Programme Area Manager (Infectious Hazard Management). Email: wijesinghep@who.int Reporting Frequency of national reports Every two months Are epidemiological and virological data integrated? Yes, both Reported via a website? No Does the country report to FluID? – Year of beginning of reporting – Frequency of reporting Yes 2018 Monthly Does the country report to FluNet? – Year of beginning of reporting – Frequency of reporting Yes 2019 Monthly Are there fixed outbreak thresholds? Yes Level at which data are stored, managed and analysed National and provincial Has formal training on data reporting and analysis been provided to surveillance and laboratory staff? – If yes, when? – Has a training session been planned? If yes, when? Yes 2019 Yes 2020 Vaccination Does the country have a formal seasonal influenza vaccination policy? No Has seasonal influenza vaccine been introduced in the public sector? – Year introduced – Recommended risk groups – Vaccination period – Northern/Southern hemisphere vaccine – Vaccine type No – – – – – Is seasonal influenza vaccine offered in the private sector? – Only offered to particular risk groups? – Vaccination period – Northern/Southern hemisphere vaccine – Vaccine type No – – – – Is vaccine offered for Hajj and Umrah pilgrims? No Vaccine production capacity No Pandemic preparedness Does the country have a National Influenza Pandemic Preparedness Plan? – Year developed? – Year updated? Yes 2009 2020 Has the country performed simulation exercises? Yes Are there laboratory testing strategies in place for different phases of an influenza pandemic? Yes Are there surge capacity plans? Yes, included in National Influenza Pandemic Preparedness Plan Does the pandemic preparedness plan include a detailed National Pandemic Vaccine Deployment Plan? – Are there priority groups? No Not relevant